BAM
IBD icon

Belpointe Asset Management’s Inspire Corporate Bond ETF IBD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,158
Closed -$669K 984
2025
Q1
$669K Buy
28,158
+10,686
+61% +$254K 0.03% 464
2024
Q4
$420K Sell
17,472
-1,158
-6% -$27.8K 0.03% 551
2024
Q3
$449K Buy
18,630
+1,004
+6% +$24.2K 0.03% 531
2024
Q2
$411K Sell
17,626
-44,524
-72% -$1.04M 0.03% 498
2024
Q1
$1.46M Sell
62,150
-7,434
-11% -$175K 0.11% 179
2023
Q4
$1.64M Sell
69,584
-8,508
-11% -$201K 0.14% 141
2023
Q3
$1.77M Sell
78,092
-2,466
-3% -$55.8K 0.18% 114
2023
Q2
$1.86M Buy
80,558
+25,208
+46% +$582K 0.2% 103
2023
Q1
$1.3M Buy
55,350
+35,066
+173% +$821K 0.07% 280
2022
Q4
$467K Buy
+20,284
New +$467K 0.03% 566
2021
Q4
Sell
-16,667
Closed -$436K 1227
2021
Q3
$436K Sell
16,667
-127
-0.8% -$3.32K 0.03% 551
2021
Q2
$441K Buy
16,794
+440
+3% +$11.6K 0.03% 538
2021
Q1
$423K Buy
+16,354
New +$423K 0.04% 487